Company news

BeOne Medicines Ltd. news in 2025

BeOne Medicines Ltd.'s news releases, calls and decks from 2025, newest first.

View company

Indicative Announcement on Equity Change of Shareholders with Over 5% Shares Reaching 1%

March 6, 2025

TEVIMBRA Approved in U.S. for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma in Combination with Chemotherapy

March 4, 2025

BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates

February 27, 2025

BeiGene to Present at Upcoming Investor Conferences

February 25, 2025

Indicative Announcement on Equity Change of Shareholders with Over 5% Shares

February 24, 2025

Announcement on Voluntary Disclosure Regarding the Company's Earnings Call

February 13, 2025

Announcement on Nomination of the Board of Directors and Changes in Members of the Corporate Governance Committee

January 20, 2025

Announcement on the Equity Registration Date for the 1st Extraordinary General Meeting (Shareholders' Special Meeting) in 2025

January 17, 2025

← Newer news releases

Calls in 2025

Decks in 2025